carnitine has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kagan, VE; Khwaja, S; Packer, L; Ramsey, R; Reznick, AZ; Serbinova, EA; Tsuchiya, M | 1 |
| El-Metwally, TH; Hamed, EA; Kamal, MM; Mohamed, NA | 1 |
3 other study(ies) available for carnitine and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation.
Topics: Animals; Carnitine; Deferoxamine; Electron Spin Resonance Spectroscopy; Energy Metabolism; Free Radical Scavengers; Free Radicals; Hydroxides; Hydroxyl Radical; Iron Chelating Agents; Luminescent Measurements; Luminol; Male; Myocardial Reperfusion Injury; Oxidation-Reduction; Rats; Rats, Inbred Strains; Stereoisomerism; Superoxides; Ventricular Function, Left | 1992 |
Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone m
Topics: beta-Thalassemia; Blood Transfusion; Bone Density; Carnitine; Case-Control Studies; Chelation Therapy; Child; Child, Preschool; Deferoxamine; Fatty Acids, Nonesterified; Female; Homozygote; Humans; Infant; Male; Osteoprotegerin; RANK Ligand; Siderophores | 2010 |